Artificial Intelligence

In this episode of Meeting Mic, we bring you expert insights from the ASH Annual Meeting and Exhibition, as well as Healio’s top headlines from the meeting.

Okogen announced completion of $3.3 million in financing to advance the company through its phase 2b clinical program for acute infectious conjunctivitis, as well as support development of an AI-driven image evaluation platform.

AI saves time for pediatric cardiac ICU clinicians by identifying patients who need more attention, according to a presenter at the AIMed24 Annual Meeting.

SAN DIEGO — The increased use of AI in health care has generated tremendous excitement for its potential to guide treatment decision-making, improve outcomes and increase efficiency.

WASHINGTON — Healio speaks with Micaela F. Bayard, MD, about AI and its integration into clinical practice for rheumatologists.

In response to an inquiring dermatologist, a group of dermatoethicists presented the benefits and risks of accepting cryptocurrency as a form of payment for services.

An AI model classified risk for prostate cancer metastasis more accurately than standard guidelines, suggesting the approach could be used to reduce overtreatment or undertreatment.

ORLANDO — In this video from the AIMed24 Annual Meeting, Krista Nelson, director of innovation development at Children’s Mercy Hospital, discusses best practices for collaboration in the AI space across institutions to improve outcomes.

INDIANAPOLIS — The use of AI may help clinicians quantify and assess meibomian gland morphology among patients with dry eye disease, according to a study presented at Academy 2024.

ORLANDO — In this video from the AIMed24 Annual Meeting, Buck Schneider, MHA, business development manager at Bayer, discusses the potential for AI solutions to solve “million-dollar problems” in radiology.